|
J. Biol. Chem., Vol. 265, Issue 19, 10865-10871, Jul, 1990
Cytochrome P-450 enzyme-specific control of the regio- and enantiofacial selectivity of the microsomal arachidonic acid epoxygenase
JH Capdevila, A Karara, DJ Waxman, MV Martin, JR Falck and FP Guenguerich
Department of Medicine (Nephrology Division), Vanderbilt University Medical School, Nashville, Tennessee 37232.
Chiral analysis of the rat liver microsomal arachidonic acid epoxygenase
metabolites shows enantioselective formation of 8,9-, 11,12- , and
14,15-cis-epoxyeicosatrienoic acids in an approximately 2:1, 4:1, and 2:1
ratio of antipodes, respectively. Animal treatment with the cytochrome
P-450 inducer phenobarbital increased the overall enantiofacial selectivity
of the microsomal epoxygenase and caused a concomitant inversion in the
absolute configurations of its metabolites. These effects of phenobarbital
were time-dependent and temporally linked to increases in the concentration
of microsomal cytochrome P-450 enzymes. Reconstitution of the epoxygenase
reaction utilizing several purified cytochrome P-450 demonstrated that the
asymmetry of epoxidation is under cytochrome P-450 enzyme control. These
results established that the chirality of the hepatic arachidonic acid
epoxygenase is under regulatory control and confirm cytochromes P- 450 IIB1
and IIB2 as two of the endogenous epoxygenases induced in vivo by
phenobarbital.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
D. J. Behm, A. Ogbonna, C. Wu, C. L. Burns-Kurtis, and S. A. Douglas
Epoxyeicosatrienoic Acids Function as Selective, Endogenous Antagonists of Native Thromboxane Receptors: Identification of a Novel Mechanism of Vasodilation
J. Pharmacol. Exp. Ther.,
January 1, 2009;
328(1):
231 - 239.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Diani-Moore, F. Papachristou, E. Labitzke, and A. B. Rifkind
INDUCTION OF CYP1A AND CYP2-MEDIATED ARACHIDONIC ACID EPOXYGENATION AND SUPPRESSION OF 20-HYDROXYEICOSATETRAENOIC ACID BY IMIDAZOLE DERIVATIVES INCLUDING THE AROMATASE INHIBITOR VOROZOLE
Drug Metab. Dispos.,
August 1, 2006;
34(8):
1376 - 1385.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Jiang, J. C. McGiff, J. Quilley, D. Sacerdoti, L. M. Reddy, J. R. Falck, F. Zhang, K. M. Lerea, and P. Y-K Wong
Identification of 5,6-trans-Epoxyeicosatrienoic Acid in the Phospholipids of Red Blood Cells
J. Biol. Chem.,
August 27, 2004;
279(35):
36412 - 36418.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Ma, J. Graves, J. A. Bradbury, Y. Zhao, D. L. Swope, L. King, W. Qu, J. Clark, P. Myers, V. Walker, et al.
Regulation of Mouse Renal CYP2J5 Expression by Sex Hormones
Mol. Pharmacol.,
March 1, 2004;
65(3):
730 - 743.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Cowart, S. Wei, M.-H. Hsu, E. F. Johnson, M. U. Krishna, J. R. Falck, and J. H. Capdevila
The CYP4A Isoforms Hydroxylate Epoxyeicosatrienoic Acids to Form High Affinity Peroxisome Proliferator-activated Receptor Ligands
J. Biol. Chem.,
September 13, 2002;
277(38):
35105 - 35112.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Benoit, B. Renaudon, D. Salvail, and E. Rousseau
EETs relax airway smooth muscle via an EpDHF effect: BKCa channel activation and hyperpolarization
Am J Physiol Lung Cell Mol Physiol,
May 1, 2001;
280(5):
L965 - L973.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Capdevila, J. R. Falck, and R. C. Harris
Cytochrome P450 and arachidonic acid bioactivation: molecular and functional properties of the arachidonate monooxygenase
J. Lipid Res.,
February 1, 2000;
41(2):
163 - 181.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
J. Ma, W. Qu, P. E. Scarborough, K. B. Tomer, C. R. Moomaw, R. Maronpot, L. S. Davis, M. D. Breyer, and D. C. Zeldin
Molecular Cloning, Enzymatic Characterization, Developmental Expression, and Cellular Localization of a Mouse Cytochrome P450 Highly Expressed in Kidney
J. Biol. Chem.,
June 18, 1999;
274(25):
17777 - 17788.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. K . Mater, A. P. Thelen, and D. B. Jump
Arachidonic acid and PGE2 regulation of hepatic lipogenic gene expression
J. Lipid Res.,
June 1, 1999;
40(6):
1045 - 1052.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
W. Qu, R. A. Rippe, J. Ma, P. Scarborough, C. Biagini, F. T. Fiedorek, G. S. Travlos, C. Parker, and D. C. Zeldin
Nutritional Status Modulates Rat Liver Cytochrome P450 Arachidonic Acid Metabolism
Mol. Pharmacol.,
September 1, 1998;
54(3):
504 - 513.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. Dumoulin, D. Salvail, S. B. Gaudreault, A. Cadieux, and E. Rousseau
Epoxyeicosatrienoic acids relax airway smooth muscles and directly activate reconstituted KCa channels
Am J Physiol Lung Cell Mol Physiol,
September 1, 1998;
275(3):
L423 - L431.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. K. Powell, I. Wolf, R. Jin, and J. M. Lasker
Metabolism of Arachidonic Acid to 20-Hydroxy-5,8,11,14-eicosatetraenoic Acid by P450 Enzymes in Human Liver: Involvement of CYP4F2 and CYP4A11
J. Pharmacol. Exp. Ther.,
June 1, 1998;
285(3):
1327 - 1336.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
D. S. Keeney, C. Skinner, S. Wei, T. Friedberg, and M. R. Waterman
A Keratinocyte-specific Epoxygenase, CYP2B12, Metabolizes Arachidonic Acid with Unusual Selectivity, Producing a Single Major Epoxyeicosatrienoic Acid
J. Biol. Chem.,
April 10, 1998;
273(15):
9279 - 9284.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. R. Harder, N. J. Alkayed, A. R. Lange, D. Gebremedhin, and R. J. Roman
Functional Hyperemia in the Brain : Hypothesis for Astrocyte-Derived Vasodilator Metabolites
Stroke,
January 1, 1998;
29(1):
229 - 234.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Zeldin, J. Foley, S. M. Goldsworthy, M. E. Cook, J. E. Boyle, J. Ma, C. R. Moomaw, K. B. Tomer, C. Steenbergen, and S. Wu
CYP2J Subfamily Cytochrome P450s in the Gastrointestinal Tract: Expression, Localization, and Potential Functional Significance
Mol. Pharmacol.,
June 1, 1997;
51(6):
931 - 943.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Wu, W. Chen, E. Murphy, S. Gabel, K. B. Tomer, J. Foley, C. Steenbergen, J. R. Falck, C. R. Moomaw, and D. C. Zeldin
Molecular Cloning, Expression, and Functional Significance of a Cytochrome P450 Highly Expressed in Rat Heart Myocytes
J. Biol. Chem.,
May 9, 1997;
272(19):
12551 - 12559.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. H. Capdevila, S. Wei, C. Helvig, J. R. Falck, Y. Belosludtsev, G. Truan, S. E. Graham-Lorence, and J. A. Peterson
The Highly Stereoselective Oxidation of Polyunsaturated Fatty Acids by Cytochrome P450BM-3
J. Biol. Chem.,
September 13, 1996;
271(37):
22663 - 22671.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. J. Alkayed, J. Narayanan, D. Gebremedhin, M. Medhora, R. J. Roman, and D. R. Harder
Molecular Characterization of an Arachidonic Acid Epoxygenase in Rat Brain Astrocytes
Stroke,
May 1, 1996;
27(5):
971 - 979.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
S. Wu, C. R. Moomaw, K. B. Tomer, J. R. Falck, and D. C. Zeldin
Molecular Cloning and Expression of CYP2J2, a Human Cytochrome P450 Arachidonic Acid Epoxygenase Highly Expressed in Heart
J. Biol. Chem.,
February 16, 1996;
271(7):
3460 - 3468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Tollet, M. Hamberg, J. Gustafsson, and A. Mode
Growth Hormone Signaling Leading to CYP2C12 Gene Expression in Rat Hepatocytes Involves Phospholipase A[IMAGE]
J. Biol. Chem.,
May 26, 1995;
270(21):
12569 - 12577.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. C. Zeldin
Epoxygenase Pathways of Arachidonic Acid Metabolism
J. Biol. Chem.,
September 21, 2001;
276(39):
36059 - 36062.
[Full Text]
[PDF]
|
 |
|
Copyright © 1990 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|